Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/7561 stock hub

TPEX/7561 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/7561is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

606.5M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/7561

In the news

Latest news · TPEX/7561

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E18.8

P25 14.4P50 18P75 31.9

ROE7.4

P25 -16.2P50 0.3P75 9.8

ROIC10.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/7561 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

TWD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	-3%
Employees Change Percent	-3.8
Enterprise value	TWD 447.9M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0007561B13
Last refreshed	2026-05-10
Market cap	TWD 606.5M
Price	TWD 19.6
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/7561
Website	https://www.bio-ray.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.32%
EV Earnings	13.89x
EV/EBIT	11.82x
EV/EBITDA	7.28x
EV/FCF	6.28x
EV/Sales	2.01x
FCF yield	11.75%
P/B ratio	1.34x
P/E ratio	18.81x
P/S ratio	2.72x
PE Ratio3 Y	148.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.01%
EBITDA Margin	27.61%
FCF margin	32%
Gross margin	47.56%
Gross Profit	TWD 105.9M
Gross Profit Growth	-1.54%
Gross Profit Growth Q	101.34%
Gross Profit Growth3 Y	16.16%
Gross Profit Growth5 Y	5.69%
Net Income	TWD 32.3M
Net Income Growth	3,118.56%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	18.52%
Profit Margin	14.48%
Profitable Years	2
ROA	4.39
Roa5y	0.13
ROCE	7.64
ROE	7.38
Roe5y	0.59
ROIC	10.07
Roic5y	0.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.33%
Cagr3y	-16.72%
Cagr5y	-6.33%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	3,533.3
EPS Growth Quarters	3
EPS Growth Years	2
FCF Growth	430.67%
FCF Growth3 Y	164.67%
OCF Growth	330.16%
OCF Growth10 Y	45.59%
OCF Growth3 Y	123.42%
OCF Growth5 Y	70.33%
Revenue Growth	10.42x
Revenue Growth Q	33.04x
Revenue Growth Years	4x
Revenue Growth3 Y	6.66x
Revenue Growth5 Y	2.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.41
Assets	TWD 536.6M
Cash	TWD 204.9M
Current Assets	TWD 294.2M
Current Liabilities	TWD 41.2M
Debt	TWD 46.3M
Debt EBITDA	TWD 0.75
Debt Equity	TWD 0.1
Debt FCF	TWD 0.65
Equity	TWD 453M
Interest Coverage	58.66
Liabilities	TWD 83.6M
Long Term Assets	TWD 242.4M
Long Term Liabilities	TWD 42.4M
Net Cash	TWD 158.6M
Net Cash By Market Cap	TWD 26.15
Net Cash Growth	108%
Net Debt EBITDA	TWD -2.58
Net Debt Equity	TWD -0.35
Net Debt FCF	TWD -2.23
Tangible Book Value	TWD 452.7M
Tangible Book Value Per Share	TWD 15.3
WACC	5.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.85
Inventory Turnover	2.16
Net Working Capital	TWD 77.5M
Quick ratio	6.05
Working Capital	TWD 278.9M
Working Capital Turnover	TWD 0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	11.42%
Dividend per share	TWD 0
Last Dividend	TWD 0.2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.33%
200-day SMA	23.35
3Y total return	-42.25%
50-day SMA	22.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-27.89%
All Time High	111.5
All Time High Change	-82.42%
All Time High Date	2020-07-06
All Time Low	18.25
All Time Low Change	7.4%
All Time Low Date	2025-04-09
ATR	0.75
Beta	0.22
Beta1y	-0.06
Beta2y	0.32
Ch YTD	-6.22
High	20.5
High52	32.1
High52 Date	2025-09-05
High52ch	-38.94%
Low	19.6
Low52	19.5
Low52 Date	2025-12-11
Low52ch	0.51%
Ma50ch	-13.8%
Price vs 200-day SMA	-16.05%
RSI	37.56
RSI Monthly	40.73
RSI Weekly	39.98
Sharpe ratio	0x
Sortino ratio	0.14
Total Return	11.42%
Tr YTD	-6.22
Tr1m	-10.91%
Tr1w	-4.85%
Tr3m	-17.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 37.9M
Operating Income Growth	6.7
Operating margin	17.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,630,918%
Net Borrowing	-45,751,000
Shares Insiders	11.2%
Shares Out	29,585,262
Shares Qo Q	-0.05%
Shares Yo Y	-11.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 71.3M
Average Volume	16,058.75x
Bv Per Share	15.31
CAPEX	TWD -369,000
Ch1m	-10.91
Ch1w	-4.85
Ch1y	-7.33
Ch3m	-17.82
Ch3y	-42.61
Ch5y	-30.12
Ch6m	-16.06
Change	-0.76%
Change From Open	0
Close	19.75
Days Gap	-0.76
Depreciation Amortization	23,593,000
Dollar Volume	744,800
Earnings Date	2026-05-12
EBIT	TWD 37.9M
EBITDA	TWD 61.5M
EPS	TWD 1.09
F Score	6
FCF	TWD 71.3M
FCF EV Yield	15.91x
FCF Per Share	TWD 2.41
Financing CF	-45,657,000
Fiscal Year End	December
Founded	2,005
Graham Number	19.37724
Graham Upside	-1.14
Income Tax	TWD 9M
Investing CF	727,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-06-30
Ma150	23.15
Ma150ch	-15.32%
Ma20	21.48
Ma20ch	-8.75%
Net CF	26,708,000
Next Earnings Date	2026-05-12
Open	19.6
P FCF Ratio	8.51
P OCF Ratio	8.47
Position In Range	0
Ppne	223,349,000
Price Date	2026-05-08
Price EBITDA	TWD 9.86
Ptbv Ratio	1.34
Relative Volume	2.71x
Revenue	222,725,000x
Tax By Revenue	4.04x
Tax Rate	21.8%
Tr6m	-16.06%
Volume	38,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/7561 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/7561 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/7561?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+11.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-11.4%

Negative means the company is buying back shares.

Technical

TPEX/7561 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.6

Neutral momentum band

Price vs 200-day MA

-16.0%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

0.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/7561

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/7561 stock rating?

tpex/7561 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/7561 analysis?

The full report lives at /stocks/tpex/7561/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/7561?

The latest report frames tpex/7561 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/7561 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.